Table 2 Intracellular inhibitors regulating PRR function
From: Negative regulation of human mononuclear phagocyte function
Inhibitory molecule | Mechanism of inhibition | Animal disease models | Human disease |
|---|---|---|---|
A20 | Ubiquitinates/deubiquitinates molecules in PRR and TNFR pathways92, 93, 94, 95 | Deficiency: • death due to severe multi-organ inflammation91 •↑endotoxin shock91 • deficiency in DCs → colitis96 | SNPs in the A20 region associated with CD,97 SLE98, 99 and RA100, 101 |
ABIN1 | • dysfunction→ SLE and autoimmunity in mice325, 326 •↑expression protects from TNF-induced death and allergic airway inflammation327, 328 | ||
ABIN3 | • inhibits NF-κB activation331 • binds A20331 | adenoviral expression in mice protects from LPS -induced death331 | |
FLN29 | • inhibits TRAF6-mediated NF-κB signaling332 • inhibits the Rig I pathway333 | FLN29−/− →↑endotoxin shock333 | |
IRAK-M | Inhibits IRAK-1 activation60 | Deficiency: •↑inflammation to microbes60 •↑lung injury64 •↑IL-10−/− colitis65 • endotoxin tolerance defect60 | Mutations↑risk for asthma;66, 67 dysregulated levels seen in necrotizing enterocolitis,68 TB69 and cystic fibrosis62 |
IRF4 | • IRF4−/− →↑DNA shock103 • IRF4 knockdown in vivo →↑experimental colitis102 | ↑ expression in mucosa of IBD patients105 | |
ITAM | Induces inhibitors, including SOCS-1, ABIN-3, A20, and IL-10112 | ITAM-containing receptors suppress inflammatory diseases, including colitis113, 114 | |
MKP-1 | Inhibits MAPK signaling334 | Deficiency: •IL-10−/− colitis335 | Impaired induction in: • alveolar macrophages from asthma patients337 • LPS-treated BAL cells from sarcoidosis patients338 |
MyD88s | Prevents MyD88 signaling by failure to recruit IRAK-4339 | •↑in monocytes during sepsis317 | |
NLRP12 | • inhibits IRAK1 phosphorylation195 • ↓’s NIK expression194 | Deficiency: •↑DSS colitis and colitis-associated cancer340 •↑Y. pestis susceptibility193 | Mutations → auto-inflammatory diseases198, 199 and atopic dermatitis200 |
PGE | • induces IRAK-M341 | Mice with prostaglandin pathway deficiency →↑colitis and colonic injury344, 345 | SNPs in a region that includes PTGER4 associated with IBD10 |
SHIP-1 | • dephosphorylates TBK1 and inhibits IFNβ induction106 • inhibits PI3K signaling107 | Deficiency: • ileitis109 • endotoxin tolerance defect107 • macrophage infiltration in bone marrow and spleen110 •↓life span110 | ↑ SHIP-1 expression in the intestinal mucosa of IBD patients111 |
SOCS-1 | Deficiency ↑’s inflammatory cytokine production and endotoxin shock72, 346 | Loss-of-function/expression SNPs:↑serum IgE78 and↑asthma79 and lymphoma347 | |
SOCS-3 | • deficiency → embryonic lethality350 • deficiency in macrophages→↑endotoxin shock351 | ↑ SOCS-3 expression in mucosal biopsies from CD patients352 | |
TOLLIP | Deficiency→↑inflammation following sublethal endotoxin356 | SNPs associated with atopic dermatitis357 and SNPs with decreased Tollip mRNA associated with TB358 | |
TWIST family | • Twist1 and Twist2 inhibit NF-κB p65 transactivation359 • Twist1 and Twist2 repress the TNF-α gene promoter82 • Twist2 induces IL-10 through c-Maf activation360 | • Twist1−/−: embryonic death361 • Twist2−/−: →perinatal death with cachexia and↑cytokines359 →endotoxin tolerance defect in macrophages360 | •↑Twist1 expression in Th1 lymphocytes in inflamed tissue from IBD and RA patients362 |
TAM receptors | • SOCS-1 and -3 induction80 | Deficiency/functional defect: •↑endotoxin shock83 |